Takanori Ito
Papers
1
Total Citations
3
H-Index
1
About
Dr. Takanori Ito is a leading interventional radiologist whose research focuses on advancing transarterial chemoembolization (TACE) for hepatocellular carcinoma. His most notable contribution is the development and clinical validation of a porous glass membrane-pumping emulsification device (GMD), which produces high-percentage water-in-oil emulsions with homogeneous, stable droplets. In his landmark 2022 study, Dr. Ito demonstrated that GMD-enhanced TACE significantly improves locoregional therapeutic effects for solitary hepatocellular carcinoma, achieving more consistent drug delivery and tumor necrosis compared to conventional methods. This work has been cited 3 times, establishing a foundation for future optimization of embolic agents. Dr. Ito’s research bridges materials engineering and interventional oncology, offering a practical solution to a longstanding challenge in chemoembolization—emulsion stability. By enabling more predictable and potent treatment outcomes, his innovations hold promise for reducing recurrence rates and improving patient survival. His ongoing investigations continue to refine GMD technology, positioning him as a key figure in the evolution of minimally invasive liver cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1